EU H2020 Project "ASSYST (A reliable CXCL4 biomarker assay to improve diagnosis and treatment of..)": description, partecipants, costs and EC-fundings

#	Pagina
attuale pagina	/open-h2020/projects/216967/index.html

ASSYSt project word cloud

Explore the words cloud of the ASSYSt project. It provides you a very rough idea of what is the project "ASSYSt" about.

tract collection disorder sclerosis demonstrated fast circumvent multiple half matrix argue outcome heart prohibits therapeutic scleroderma medical levels tool autoimmune assessing measuring deposition protocols erc grant adequately patients organ replication treatment exacerbated molecular complications disease team vitro listed irrespective course lacking strategy systemic ssc internal strategies curative die clinical skin sensitive central ultimately prevention complicates accelerate business complement unclear cxcl4 biomarker scarring assist extracellular player joints treatments lung labs circulating kidneys assay diagnosis fibrosis excessive assyst experiments aetiology market route culminating cheap starting organs suggest diagnostic pathogenesis validate cohorts of tissue markers storage predict decision prognosis accessible guide chemokine lack gastrointestinal

Project "ASSYSt" data sheet

The following table provides information about the project.

Coordinator	UNIVERSITAIR MEDISCH CENTRUM UTRECHT Organization address address: HEIDELBERGLAAN 100 city: UTRECHT postcode: 3584 CX website: www.umcutrecht.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Netherlands [NL]
Total cost	150˙000 €
EC max contribution	150˙000 € (100%)
Programme	1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
Code Call	ERC-2017-PoC
Funding Scheme	ERC-POC
Starting year	2018
Duration (year-month-day)	from 2018-08-01 to 2020-01-31

#	participants	country	role	EC contrib. [€]
1	UNIVERSITAIR MEDISCH CENTRUM UTRECHT	NL (UTRECHT)	coordinator	150˙000.00

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

NL (UTRECHT)

coordinator

150˙000.00

Project objective

Systemic Sclerosis (SSc, scleroderma) is a complex autoimmune disorder of unclear aetiology, culminating in excessive extracellular matrix deposition (fibrosis/tissue scarring) in skin and internal organs (e.g. joints, heart, lung, gastrointestinal tract and kidneys). More than half of the patients will ultimately die as a result of organ complications. The medical need is exacerbated by the lack of curative treatments and the lack of specific and sensitive molecular markers to facilitate reliable diagnosis and prognosis.

My team has recently demonstrated, through research funded by the ERC Starting Grant CIRCUMVENT, that the chemokine CXCL4 is a central player in the pathogenesis of SSc. Our results suggest that CXCL4 has great potential as 1) a biomarker to assist early diagnosis, 2) a biomarker to predict SSc disease course, and 3) a therapeutic target for the treatment or prevention of fibrosis in patients with SSc. Currently, a robust, accessible, reliable, cheap and fast assay to determine CXCL4 levels for clinical use is lacking. This prohibits the use of CXCL4 to predict clinical and treatment outcome and complicates the large-scale replication experiments across multiple labs and cohorts that are necessary to validate the diagnostic value of CXCL4.

Therefore, we argue that a reliable in vitro assay measuring circulating CXCL4 levels is highly needed and can be deployed as a research support tool to accelerate the implementation of clinical strategies based on CXCL4 and a clinical decision support tool in SSc to complement current diagnostic protocols. ASSYSt will focus on 1) the development of a reliable assay to adequately determine circulating CXCL4 levels irrespective of sample collection and storage conditions, 2) assessing the market potential of each of the applications listed above, and 3) defining a strong business strategy to guide route to market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ASSYST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ASSYST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

HyperCube (2020)

HyperCube: Gram scale production of ferrite nanocubes and thermo-responsive polymer coated nanocubes for medical applications and further exploitation in other hyperthermia fields